Abacus FCF Innovation Leader Mutual Fund logo

Abacus FCF Innovation Leader Mutual Fund (ABOT)

Market Closed
2 Jul, 20:00
BATS BATS
$
39. 77
+0.34
+0.875%
$
- Market Cap
0.86% Div Yield
1 Volume
$ 39.43
Previous Close
Investors:
Add Transaction
Day Range
39.52 39.83
Year Range
32.14 41.94
Want to track ABOT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ABOT closed Thursday higher at $39.77, an increase of 0.875% from Wednesday's close, completing a monthly increase of 0.0629% or $0.02. Over the past 12 months, ABOT stock gained 1.9088%.
ABOT pays dividends to its shareholders, with the most recent payment made on Jun 30, 2026. The next estimated payment will be in In 2 months on Sep 30, 2026 for a total of $0.02736.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on BATS (USD).

ABOT Chart

Abacus FCF Innovation Leader Mutual Fund Investors

Name Quantity Cost Value Profit ($) Gain (%)
KLM
Kevin L. Mccreless CONCOURSE FINANCIAL GROUP SECURITIES Inc.
2,109 $56,415.75 $83,853.84 $27,438.09 48.64%

Abacus FCF Innovation Leader Mutual Fund (ABOT) FAQ

What is the stock price today?

The current price is $39.77.

On which exchange is it traded?

Abacus FCF Innovation Leader Mutual Fund is listed on BATS.

What is its stock symbol?

The ticker symbol is ABOT.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.86%.

What is its market cap?

As of today, no market cap data is available.

Has Abacus FCF Innovation Leader Mutual Fund ever had a stock split?

No, there has never been a stock split.

Abacus FCF Innovation Leader Mutual Fund Profile

BATS Exchange
US Country

Overview

The fund described aims to fulfill its investment objective by allocating at least 80% of its net assets, alongside any borrowings intended for investment purposes, into the component securities that make up its index. This index has been specifically crafted to monitor the performance of a strategy focused on investing in U.S. publicly traded companies. A distinctive feature of these targeted companies is their robust free cash flow alongside significant investments in research and development (R&D), signaling a commitment to innovation and growth. By following this approach, the fund seeks to offer investors equity exposure to firms that are not only financially healthy but are also at the forefront of technological and industrial advancements, potentially paving the way for sustained profitability and market leadership.

Products and Services

  • Component Securities Investment

    The core product of the fund involves the investment in component securities of the targeted index. This index is meticulously constructed to include U.S. publicly traded companies distinguished by their strong free cash flow and aggressive R&D investments. This investment strategy is designed to optimize equity exposure to high-performing companies, thereby offering the potential for robust returns to investors.

  • Equity Exposure to High-Performing Companies

    By focusing on companies with strong free cash flow and significant R&D expenditure, the fund aims to provide investors with exposure to firms that are not only financially solid but are also leaders in innovation. This dual focus ensures that investors benefit from both the protective measures of financial health and the growth potential offered by cutting-edge research and development efforts.

Contact Information

Address: -
Phone: 415.887.9225